Variability of NT-proBNP levels in heart failure: implications for clinical application
- PMID: 17639105
- PMCID: PMC1994424
- DOI: 10.1136/hrt.2006.110643
Variability of NT-proBNP levels in heart failure: implications for clinical application
Abstract
See article on page 957
Conflict of interest statement
Conflict of interest: None declared
Comment on
-
Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study.Heart. 2007 Aug;93(8):957-62. doi: 10.1136/hrt.2006.096891. Epub 2007 May 8. Heart. 2007. PMID: 17488774 Free PMC article.
Similar articles
-
Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study.Heart. 2007 Aug;93(8):957-62. doi: 10.1136/hrt.2006.096891. Epub 2007 May 8. Heart. 2007. PMID: 17488774 Free PMC article.
-
Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.Int J Cardiol. 2008 Oct 13;129(3):373-8. doi: 10.1016/j.ijcard.2007.07.126. Epub 2007 Dec 4. Int J Cardiol. 2008. PMID: 18054808
-
Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.J Card Fail. 2013 Jan;19(1):31-9. doi: 10.1016/j.cardfail.2012.11.002. J Card Fail. 2013. PMID: 23273592
-
Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.Am J Cardiol. 2008 Feb 4;101(3A):29-38. doi: 10.1016/j.amjcard.2007.11.017. Am J Cardiol. 2008. PMID: 18243855 Review.
-
[NT-proBNP in practice: from chemistry to medicine].Ann Biol Clin (Paris). 2009 May-Jun;67(3):255-71. doi: 10.1684/abc.2009.0331. Ann Biol Clin (Paris). 2009. PMID: 19411228 Review. French.
Cited by
-
Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy.Eur J Heart Fail. 2021 Jun;23(6):895-905. doi: 10.1002/ejhf.2198. Epub 2021 May 24. Eur J Heart Fail. 2021. PMID: 33915002 Free PMC article. Review.
-
Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations.J Am Heart Assoc. 2019 Aug 6;8(15):e012228. doi: 10.1161/JAHA.119.012228. Epub 2019 Aug 5. J Am Heart Assoc. 2019. PMID: 31379241 Free PMC article.
-
CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study.J Cardiovasc Transl Res. 2016 Aug;9(4):302-14. doi: 10.1007/s12265-016-9703-3. Epub 2016 Jun 6. J Cardiovasc Transl Res. 2016. PMID: 27271043
-
Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF.Cardiovasc Res. 2024 Jul 31;120(9):999-1010. doi: 10.1093/cvr/cvae095. Cardiovasc Res. 2024. PMID: 38728438 Free PMC article.
-
The Predictivity of N-Terminal Pro b-Type Natriuretic Peptide for All-Cause Mortality in Various Follow-Up Periods among Heart Failure Patients.J Clin Med. 2019 Mar 13;8(3):357. doi: 10.3390/jcm8030357. J Clin Med. 2019. PMID: 30871208 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials